HemaSphere (May 2023)

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

  • M.R. Seefat,
  • C.A.M. Stege,
  • G.J. Timmers,
  • M.D. Levin,
  • M. Hoogendoorn,
  • P.F. Ypma,
  • I.S. Nijhof,
  • G.A. Velders,
  • L. Strobbe,
  • N. Durdu-Rayman,
  • M. Westerman,
  • M.A. Davidis-van Schoonhoven,
  • R.J.W. van Kampen,
  • A. Beeker,
  • A. Koster,
  • A.C. Dijk,
  • N.W.C.J. van de Donk,
  • E. van der Spek,
  • M.B.L. Leys,
  • M.H. Silbermann,
  • K. Groen,
  • N.C.H.P. van der Burg-de Graauw,
  • H.A.M. Sinnige,
  • K.G. van der Hem,
  • T.H. Levenga,
  • Y.M. Bilgin,
  • P. Sonneveld,
  • S.K. Klein,
  • K. Nasserinejad,
  • H.M. Blommestein,
  • D.G.J. Cucchi,
  • B.I. Lissenberg-Witte,
  • S. Zweegman

DOI
https://doi.org/10.1097/01.HS9.0000936176.74423.76
Journal volume & issue
Vol. 7, no. S2
pp. 16 – 16

Abstract

Read online

No abstracts available.